Genetic background and sex control the outcome of high-fat diet feeding in mice

被引:0
|
作者
Bachmann, Alexis Maximilien [1 ]
Morel, Jean-David [1 ]
El Alam, Gaby [1 ]
Rodriguez-Lopez, Sandra [1 ]
de Lima, Tanes Imamura [1 ]
Goeminne, Ludger J. E. [1 ]
Benegiamo, Giorgia [1 ]
Loric, Sylvain [2 ]
Conti, Marc [2 ,3 ]
Sleiman, Maroun Bou [1 ]
Auwerx, Johan [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Integrat Syst Physiol, CH-1015 Lausanne, Switzerland
[2] St Antoine Univ Hosp, Inserm, U938, CRSA, Paris, France
[3] Integracell, Longjumeau, France
基金
欧盟地平线“2020”; 欧洲研究理事会; 瑞士国家科学基金会; 新加坡国家研究基金会;
关键词
METABOLIC SYNDROME; MOUSE; DIVERSITY; OBESITY; MODELS;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The sharp increase in obesity prevalence worldwide is mainly attributable to changes in physical activity and eating behavior but the metabolic and clinical impacts of these obesogenic conditions vary between sexes and genetic backgrounds. This warrants personalized treatments of obesity and its complications, which require a thorough understanding of the diversity of metabolic responses to high-fat diet intake. By analyzing nine genetically diverse mouse strains, we show that much like humans, mice exhibit a huge variety of physiological and biochemical responses to high-fat diet. The strains exhibit various degrees of alterations in their phenotypic makeup. At the transcriptome level, we observe dysregulations of immunity, translation machinery, and mitochondrial genes. At the biochemical level, the enzymatic activity of mitochondrial complexes is affected. The diversity across mouse strains, diets, and sexes parallels that found in humans and supports the use of diverse mouse populations in future mechanistic or preclinical studies on metabolic dysfunctions.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Atherogenic high-fat diet reduces bone mineralization in mice
    Parhami, F
    Tintut, Y
    Beamer, WG
    Gharavi, N
    Goodman, W
    Demer, LL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) : 182 - 188
  • [42] HIGH-FAT DIET ACCELERATES LUPUS NEPHRITIS IN AUTOIMMUNE MICE
    KELLEY, VE
    IZUI, S
    KIDNEY INTERNATIONAL, 1981, 19 (01) : 184 - 184
  • [43] Effect of high-fat diet and empagliflozin on cardiac proteins in mice
    Xiaoyu Pan
    Shuchun Chen
    Xing Chen
    Qingjuan Ren
    Lin Yue
    Shu Niu
    Zelin Li
    Ruiyi Zhu
    Xiaoyi Chen
    Zhuoya Jia
    Ruoxi Zhen
    Jiangli Ban
    Nutrition & Metabolism, 19
  • [44] The effect of a high-fat diet and exercise on the expression of genetic obesity
    Metzger, BL
    Jarosz, PA
    Noureddine, S
    WESTERN JOURNAL OF NURSING RESEARCH, 2000, 22 (06) : 736 - 748
  • [45] Effects of a high-fat diet on the lipid profile of oocytes in mice
    Brusentsev, E. Yu
    Chuyko, E. A.
    Okotrub, K. A.
    Igonina, T. N.
    Rozhkova, I. N.
    Ragaeva, D. S.
    Ranneva, S., V
    Naprimerov, V. A.
    Amstislavsky, S. Ya
    VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2020, 24 (05): : 533 - 538
  • [46] Effect of high-fat diet and empagliflozin on cardiac proteins in mice
    Pan, Xiaoyu
    Chen, Shuchun
    Chen, Xing
    Ren, Qingjuan
    Yue, Lin
    Niu, Shu
    Li, Zelin
    Zhu, Ruiyi
    Chen, Xiaoyi
    Jia, Zhuoya
    Zhen, Ruoxi
    Ban, Jiangli
    NUTRITION & METABOLISM, 2022, 19 (01)
  • [47] Effect of a high-fat diet and iron overload on erythropoiesis in mice
    Varghese, Joe
    Varghese, Jithu James
    Jacob, Molly
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2025, 41
  • [48] Fecal Viral Community Responses to High-Fat Diet in Mice
    Schulfer, Anjelique
    Santiago-Rodriguez, Tasha M.
    Ly, Melissa
    Borin, Joshua M.
    Chopyk, Jessica
    Blaser, Martin J.
    Pride, David T.
    MSPHERE, 2020, 5 (01)
  • [49] A novel mechanism for barrier dysfunction in mice on a high-fat diet
    Stenman, L.
    Holma, R.
    Korpela, R.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 149 - 149
  • [50] NEUROBEHAVIORAL ADAPTATIONS TO A REWARDING HIGH-FAT AND -SUGAR DIET IN MICE
    Fulton, Stephanie
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 : E2 - E2